The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND AND OBJECTIVE: Nitazoxanide, a US Food and Drug Administration-approved antiparasitic agent, was reported to be effective in treating coronavirus disease 2019 (COVID-19). The lack of effective and precise treatments for COVID-19 infection earlier in the pandemic forced us to depend on sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuelazm, Mohamed, Ghanem, Ahmed, Awad, Ahmed K., Farahat, Ramadan Abdelmoez, Labieb, Fatma, Katamesh, Basant E., Abdelazeem, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628625/
https://www.ncbi.nlm.nih.gov/pubmed/36315350
http://dx.doi.org/10.1007/s40261-022-01213-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628625/
https://www.ncbi.nlm.nih.gov/pubmed/36315350
http://dx.doi.org/10.1007/s40261-022-01213-y

Ejemplares similares